EC Number |
Inhibitors |
Structure |
---|
3.1.1.4 | (+-)-3-O-[4-(4,5-dihydro-5-oxo-1,2,4-4H-oxadiazol-3-yl)phenyl]-2-O-tetradecyl-1-O-triphenylmethylglycerol |
- |
|
3.1.1.4 | (2-(2-amino-2-oxoethyl)-5-propyl-1H-indol-7-yl)acetic acid |
- |
|
3.1.1.4 | (2-(4-((3-(diphenylmethyl)-2,4-dioxo-3,4-dihydroquinazolin-1(2H)-yl)methyl)phenyl)-1,3-oxazol-4-yl)acetic acid |
- |
|
3.1.1.4 | (2E,4E,6S)-6-[(2-oxohexadecanoyl)amino]deca-2,4-dienoic acid |
reduces the cellular release of arachidonic acid by 6% |
|
3.1.1.4 | (2E,4S)-4-[(2-oxohexadecanoyl)amino]oct-2-enoic acid |
reduces the cellular release of arachidonic acid by 74% |
|
3.1.1.4 | (3-aminooxalyl-1-benzyl-2-ethyl-6-methyl-1H-indol-4-yl)oxyacetic acid methyl ester |
LY374388, potent sPLA2 inhibitor |
|
3.1.1.4 | (3E)-3-[(3aS,7aS)-3-methyl-2-oxo-6-(propan-2-ylidene)hexahydro-1-benzofuran-7(4H)-ylidene]propanoic acid |
non-competitive inhibition |
|
3.1.1.4 | (3R,3aS,5aS,8bR)-3,5a,5b-trimethyl-3a,4,5,5a,5b,8b-hexahydro-2H-cyclopenta[2,3]cyclopropa[1,2-g]benzofuran-2,6(3H)-dione |
non-competitive inhibition |
|
3.1.1.4 | (3R,3aS,5aS,9bR)-3,5a,9-trimethyl-3a,4,5,5a-tetrahydronaphtho[1,2-b]furan-2,8(3H,9bH)-dione |
non-competitive inhibition |
|
3.1.1.4 | (3R,3aS,6R,8S,9bS)-6,8-dihydroxy-3,6,9-trimethyl-3,3a,4,5,6,6a,7,8-octahydroazuleno[4,5-b]furan-2(9bH)-one |
non-competitive inhibition |
|